MedTrace Logo

Effect of Dexmedetomidine and Propofol on Regional Cerebral Tissue Oxygen Saturation

NCT03817112 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-01-25

No results posted yet for this study

Summary

50 patients divided into 2 groups

.Group I Dexmedetomidine infusion. Group II with Propofol infusion

Conditions

  • Regional Cerebral Tissue Oxygen Saturation

Interventions

DRUG

Dexmedetomidine Hydrochloride 0.1 MG/ML

Dexmedetomidine Hydrochloride 0.1 MG/ML infusion at 0.2-0.7 mcg/kg/min

DRUG

Propofol 10 MG/ML

Propofol 10 MG/ML infusion at 0.3 -4 mg/kg/h

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-15
Primary Completion
2018-09-30
Completion
2019-01-21

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03817112 on ClinicalTrials.gov